Kd. Wu et al., Expression and localization of human dopamine D2 and D4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma, J CLIN END, 86(9), 2001, pp. 4460-4467
Aldosterone secretion is evidently regulated by a dopaminergic inhibitory m
echanism. Pharmacological characterization and autoradiographic studies rev
ealed D2-like receptors in the adrenal cortex, especially in the zona glome
rulosa. However, the subtype of the dopamine receptors involving this regul
ation has not been elucidated. To investigate which sub-type of receptors e
xpresses in the adrenal cortex, we examined the messages of D2-like recepto
rs, D2, D3, and D4, by RT-PCR and in situ hybridization of adrenal glands a
nd adrenal neoplasm. Both D2 and D4 receptors were expressed in normal adre
nal glands, pheochromocytoma, and aldosterone-producing adenoma. However, t
he D2 receptors were not universally expressed, in contrast with the D4 rec
eptors that were detected in all cases of aldosterone-producing adenoma and
adrenal remnant. No D3 receptor message was detected by RT-PCR in any adre
nal sample. Both D2 and D4 receptors were expressed in significant amounts
in the adrenal medulla and pheochromocytoma. In the adrenal cortex, the exp
ression of the D2 receptors was in the zona glomerulosa and zona reticulari
s, with no different signal intensities between the two zones. D4 receptors
were mainly localized in the zona glomerulosa and, to a lesser extent, in
the zona reticularis. Both receptors were expressed at low levels in the zo
na fasciculata. In aldosterone-producing adenoma, the expression of D2 and
D4 was especially found in nonzona fasciculata-like cells. To elucidate whi
ch dopamine receptor regulates aldosterone secretion, the effects of specif
ic D2 and D4 antagonists, raclopride and clozapine, respectively, were exam
ined in cultured NCI-H295 cells. Dopamine further increased angiotensin II-
induced aldosterone secretion by 20%. In the presence of 1 muM dopamine and
angiotensin II, 10(-5)-10(-7) M clozapine decreased aldosterone levels by
40-55%. The decrease in aldosterone secretion by clozapine was completely r
eversed when raclopride was added simultaneously. These data suggest that d
opamine exerts dual effects on aldosterone secretion in NCI-H295 cells. Act
ivation of D4 receptors can increase aldosterone secretion, whereas an inhi
bitory effect is mediated via D2 receptors. In summary, we demonstrated the
existence of both D2 and D4 receptors in the human adrenal gland and adren
al neoplasm. Both receptors play significant roles in the modulation of ald
osterone secretion, but in opposite directions.